Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block

British Journal of Anaesthesia

Volumn 96, Issue 1, 2006, Pages 36-43

  Shields, M ^a   Giovannelli, M ^b   Mirakhur, R K ^a   Moppett, I ^b   Adams, J ^a   Hermens, Y ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c NV ORGANON   (Netherlands)

Author keywords

Antagonists, Org 25969 (sugammadex); Cyclodextrins; Neuromuscular blocking agents, rocuronium

Indexed keywords

ALFENTANIL; AMIODARONE; BENDROFLUMETHIAZIDE; DIGOXIN; FENTANYL; MORPHINE; NITROUS OXIDE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SUGAMMADEX;

ACCELEROMETRY; ADULT; AGITATION; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DYSPNEA; FEMALE; FEVER; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; LUNG INSUFFICIENCY; MALE; NAUSEA; NEUROMUSCULAR BLOCKING; POLYURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINE RETENTION; VOMITING; XEROSTOMIA;

EID: 31144448393     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aei314     Document Type: Article

References (31)

1. Berchner VL. Clinical syndrome of incomplete neuromuscular block reversal: Doctor, look at your patient. Anesth Analg 1971; 50: 876-8
2. Kirkegaard-Nielson H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS, Jensen EW. Optimun time for neostigmine reversal of atracurium-induced neuromuscular blockade. Can J Anaesth 1996; 43: 932-8
3. van den Broek L, Proost JH Wierda JM. Early and late reversal of rocuronium bromide. Eur J Anaesthesiol 1994; 9: 128-32
4. Reid JE, Breslin DS, Mirakhur RK, Hayes AH. Neostigmine antagonism of rocuronium block during anaesthesia with sevofluorane, isofluorane or propofol. Can J Anaesth 2002; 49: 635-6
5. Mosher G, Thompson DO. Complexation and cyclodextrins. Encyclopedia of Pharmaceutical Technology, 2002. Available from http://www2.dekker.com/sdek/abstract~db=enccontent=a713491640
6. Szente L, Szejtli J. Highly soluble cyclodextrin derivatives: Chemistry, properties and trends in development. Adv Drug Deliv Rev 1999; 36: 17-28
7. Matsuda H, Arima H. Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev 1999; 36: 81-99
8. Merkus FWHM, Verhoef JC, Marttin E, et al. Cyclodextrins in nasal drug delivery. Adv Drug Deliv Rev 1999; 36: 41-57
9. Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev 1999; 36: 125-41
10. Sikharam S, Egan TD, Kern SE. Cyclodextrins as new formulation entities and therapeutic agents. Curr Opin Anaesthesiol 2005; 18: 392-5
11. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin synthetic host. Angew Chem Int Ed Engl 2002; 41: 266-70
12. Zhang MQ. Drug-specific cyclodextrins: The future of rapid neuromuscular reversal? Drugs Future 2003; 28: 347-54
13. Gijsenbergh F, Ramael S, De Bruyn S, Rietbergen H, van Iersel T. Preliminary assessment of Org 25969 as a reversal agent for rocuronium in healthy male volunteers. Anesthesiology 2002; 95: A1018
14. Sorgenfrei I, Larsen PB, Norrild K, et al. Rapid reversal of rocuronium by the cyclodextrin Org 25969: A two centre dose finding and safety study. Eur J Anaesthesiol 2004; 21: 140
15. Vermeyen K, Sparr H, Beaufort A, et al. Reversal of rocuronium induced neuromuscular blockade by Org 25969: Efficacy and safety. Abstracts of the World Congress of Anaesthesiologists 2004; S072
16. McCarthy GJ, Cooper R, Stanley JC, Mirakhur RK. Dose-response relationships for neostigmine antagonism of vecuronium-induced neuromuscular blocks in adults and the elderly. Br J Anaesth 1992; 69: 281-3
17. Naguib M, Abdulatif M, al-Ghamdi A. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade. Anesthesiology 1993; 79: 739-45
18. Bom A, Mason R, Hope F, et al. The cyclodextrin derivative Org 25969, which forms complexes with steroidal neuromuscular blocking agents, causes selective reversal of normal and profound neuromuscular block. Anesthesiology 2002; 95: A1020
19. Tarver GJ, Grove SJ, Buchanan K, et al. 2-O-substituted cyclodextrins as reversal agents for the neuromuscular blocker rocuronium bromide. Bioorg Med Chem 2002; 10: 1819-27
20. Epemolu O, Bom A, Hope F, Mason R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003; 99: 632-7
21. D'Souza VT, Lipkowitz KB. Cyclodextrins (thematic issue). Chem Rev 1998; 98: 1741-2
22. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695-703
23. Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59-74
24. Eikermann M, Groeben H, Hüsing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98: 1333-7
25. Dahaba AA, Rehak PH, List WF. Assessment of accelerography with the TOF-GUARD: A comparison with electromyography. Eur J Anaesthesiol 1997; 14: 623-9
26. Driessen JJ, Robertson EN, Booji LH. Acceleromyography in neonates and small infants: Baseline calibration and recovery of the responses after neuromuscular blockade with rocuronium. Eur J Anaesthesiol 2005; 22: 11-15
27. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology 2004; 100: 1119-24
28. Kopman AF, Chin W, Cyriac J. Acceleromyography vs electromyography: An ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation. Acta Anaesthesiol Scand 2005; 49: 316-22
29. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56: 312-8
30. Fielder DL, Nelson DC, Andersen TW, Gravenstein JS. Cardiovascular effects of atropine and neostigmine in man. Anesthesiology 1969; 30: 637-41
31. Mirakhur RK, Dundee JW, Jones CJ, Coppel DL, Clarke RSJ. Reversal of neuromuscular blockade: Dose determination studies with atropine and glycopyrrolate given before or in a mixture with neostigmine. Anesth Analg 1981; 60: 557-62